Gebelik ve Astım
Özet
Astım, gebelikte en sık görülen kronik solunum yolu hastalığı olup, hamilelerin yaklaşık %3-12'sini etkilemektedir. Gebelik döneminde hastaların üçte birinde semptomlar kötüleşirken, diğerlerinde hafifleme veya stabil seyir izlenmektedir. Astım tanısı gebe olmayanlarla aynı yöntemlerle konulurken, provokasyon ve deri testlerinden kaçınılmalıdır. Gebelikte astım tedavisinin temel amacı, hem anneyi korumak hem de bebeğin hipoksiye maruz kalmasını önlemek adına astım kontrolünü sağlamaktır. Tedavide kortikosteroidler, beta2-agonistler ve lökotrien antagonistleri gibi kontrol edici ve kurtarıcı ilaçlar kullanılır. Özellikle budesonid, gebelikte güvenle tercih edilen B grubu bir inhale steroiddir. Kısa etkili beta2-agonistlerden ise terbutalin önceliklidir. Gebelikte en önemli sorunlardan biri, ilaçların yan etkilerinden korkularak tedavinin aniden kesilmesidir; bu durum kontrolsüz astıma, preeklampsiye ve düşük doğum ağırlıklı bebek riskine yol açabilir. Akut ataklarda oksijen satürasyonunun %95'in üzerinde tutulması kritiktir. Emzirme döneminde ise ilaçların süte geçişi çok düşük olduğundan rutin tedaviye güvenle devam edilmelidir. Sonuç olarak, multidisipliner yaklaşımla yakından takip edilen ve iyi kontrol edilen astım, anne ve bebek sağlığı için ciddi bir risk oluşturmamaktadır.
Asthma is the most common chronic respiratory disease encountered during pregnancy, affecting approximately 3-12% of pregnant women globally. During pregnancy, the clinical course varies, with one-third of patients experiencing worsening symptoms, one-third showing improvement, and the remaining third staying stable. Diagnosis remains similar to non-pregnant patients, though provocation and skin tests are avoided. The primary goal of management is achieving optimal asthma control to prevent maternal complications and fetal hypoxia. Pharmacotherapy includes controllers and relievers like inhaled corticosteroids, beta2-agonists, and leukotriene receptor antagonists. Budesonide is a preferred Category B inhaled steroid due to its safety profile, while terbutalin is favored among short-acting beta2-agonists. A major clinical challenge is the unauthorized cessation of routine medications due to safety fears, which increases the risk of preeclampsia, preterm birth, and low birth weight. During acute exacerbations, maintaining maternal oxygen saturation above 95% is vital. During lactation, asthma medications can be safely continued as their secretion into breast milk is minimal. In conclusion, well-controlled asthma with monthly monitoring does not pose significant risks to maternal or fetal health.
Referanslar
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2022. www.ginasthma.org
Sakar A, Yorgancıoğlu A, Dinç G, Yüksel H, Çelik P, Dağyıldızı L ve ark. The prevalence of asthma and allergic symptoms in Manisa, Turkey. Asian Pac J Allergy Immunol 2006 Mar; 24(1): 17-25.
Akcay A, Tamay Z, Dağdeviren E, Güler N, Öneş U, Kara CO ve ark. Childhood asthma and its relationship with tonsillar tissue. Asian Pac J Allergy Immunol 2006 Jun-Sep; 24(2-3): 129-34.
Türktaş İ, Selçuk ZT, Kalyoncu AF. Prevalence of asthma-associated symptoms in Turkish children. Turk J Pediatr 2001 Jan-Mar; 43(1): 1-11.
Öneş Ü, Akçay A, Tamay Z, Güler N, Zencir M. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006 Dec; 61(12): 1448-1453.
Zeyrek CD, Zeyrek F, Sevinç E, Demir E. Prevalence of asthma and allergic diseases in Şanlıurfa, Turkey, and the relation to environmental and socioeconomic factors: is the hygiene hypothesis enough? J Investig Allergol Clin Immunol 2006; 16(5): 290-295.
Öneş Ü, Sapan N, Somer A, Dişçi R, Salman N, Güler N ve ark. Prevalence of childhood asthma in İstanbul, Turkey. Allergy 1997 May; 52(5): 570-575.
Küçüködük S, Aydın M, Çetinkaya F, Dinç H, Gürses N, Saraçlar Y. The prevalence of asthma and other allergic diseases in a province of Turkey. Turk J Pediatr 1996 Apr-Jun; 38(2): 149-153.
Ece A, Ceylan A, Saraçlar Y, Saka G, Gürkan F, Haspolat K. Prevalence of asthma and other allergic disorders among schoolchildren in Diyarbakır, Turkey. Turk J Pediatr 2001 Oct-Dec; 43(4): 286-292.
Kalyoncu AF, Demir AU, Özçakar B, Bozkurt B, Artvinli M. Asthma and allergy in Turkish university students: two cross-sectional surveys 5 years apart. Allergol Immunopathol (Madr) 2001 Nov-Dec; 29(6): 264-271.
Akkurt I, Sümer H, Özşahin SL, Gönlügür U, Özdemir L, Doğan O ve ark. Prevalence of asthma and related symptoms in Sivas, Central Anatolia. J Asthma 2003; 40(5): 551-556.
Bayram I, Güneser-Kendirli S, Yılmaz M, Altıntaş DU, Alparslan N, Bingöl-Karakoç G. The prevalence of asthma and allergic diseases in children of school age in Adana in southern Turkey. Turk J Pediatr 2004 Jul-Sep; 46(3): 221-225.
Emri S, Turnagöl H, Başoğlu S, Bacanlı S, Güven GS, Aslan D. Asthma-like symptoms prevalence in five Turkish urban centers. Allergol Immunopathol (Madr) 2005 Sep-Oct; 33(5): 270-6.
Dinmezel S, Oğus C, Erengin H, Çilli A, Özbudak O, Özdemir T. The prevalence of asthma, allergic rhinitis and atopy in Antalya, Turkey. Allergy Asthma Proc 2005 Sep-Oct; 26(5): 403-409.
Hamzaçebi H, Ünsal M, Kayhan S, Bilgin S, Ercan S. Prevalence of asthma and respiratory symptoms by age, gender and smoking behaviour in Samsun, North Anatolia, Turkey. Tuberk Toraks 2006; 54(4): 322-329.
Anlar FY, Sancak R, Öztürk F. Childhood allergic disorders in Samsun, Turkey: discrepancy between reported and diagnosed. Pediatr Allergy Immunol 2006 Dec; 17(8): 635-638.
Saraçlar Y, Şekerel BE, Kalaycı O, Çetinkaya F, Adalıoğlu G, Tuncer A ve ark. Prevalence of asthma symptoms in school children in Ankara, Turkey. Respir Med 1998 Feb; 92(2): 203-207.
Yolsal GE, Yazıcıoğlu M, Türe M, Kurt I. Prevalance of asthma among preschool children in Edirne, Turkey. Asian Pac J Allergy Immunol 2007 Jun-Sep; 25(2-3):111-119.
Karaman O, Turgut CS, Uzuner N, Ölmez D, Babayiğit A, Köse S ve ark. The determination of asthma, rhinitis, eczema and atopy prevalence in 9 to 11-year-old children in the city of İzmir. Allergy Asthma Proc 2006 Jul-Aug; 27(4):319-324.
Tomaç N, Demirel F, Acun C, Ayoğlu F. Prevalence and risk factors for childhood asthma in Zonguldak, Turkey. Allergy Asthma Proc 2005 Sep-Oct; 26(5):397-402.
Kalyoncu AF, Selçuk ZT, Enünlü T, Demir AU, Çöplü L, Şahin AA ve ark. Prevalance of asthma and allergic diseases in primary school children in Ankara, Turkey: two cross-sectional studies, five years apart. Pediatr Allergy Immunol 1999 Nov; 10(4):261-265.
Gemicioğlu B. Tanımdan Tedaviye Astım. İstanbul: Turgut Yayıncılık ve Ticaret AŞ; 2004.
Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. Geographic variability in childhood asthma prevalence in Chicago. J Allergy Clin Immunol 2008 Mar; 121(3): 639-645.
Türk Toraks Derneği Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi, Ankara; 2020. ISBN: 978-605-74980-0-7.
Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006 Feb;61(2):169-176. doi: 10.1136/thx.2005.049718. PMID: 16443708; PMCID: PMC2104591.
Vatti RR, Teuber SS. Asthma and pregnancy. Clin Rev Allergy Immunol 2012 Aug;43(1-2):45-56. doi: 10.1007/s12016-011-8277-8. PMID: 21858482.
Nelson-Piercy C. Asthma in pregnancy. Thorax 2001 Apr;56(4):325-328. doi: 10.1136/thorax.56.4.325. PMID: 11254828; PMCID: PMC1746013.
Jana N, Vasishta K, Saha SC, Khunnu B. Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome. J Obstet Gynaecol (Tokyo 1995). 1995 Jun;21(3):227-232. doi: 10.1111/j.1447-0756.1995.tb01002.x. PMID: 8590358.
Schatz M, Zeiger RS, Hoffman CP, Harden K, Forsythe A, Chilingar L, Saunders B, Porreco R, Sperling W, Kagnoff M, et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 1995 Apr;151(4):1170-1174. doi: 10.1164/ajrccm/151.4.1170. PMID: 7697248.
Gordon M, Niswander KR, Berendes H, Kantor AG. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma. Am J Obstet Gynecol 1970 Feb 1;106(3):421-429. doi: 10.1016/0002-9378(70)90371-6. PMID: 5410878.
Stenius-Aarniala BS, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996 Apr;51(4):411-414. doi: 10.1136/thx.51.4.411. PMID: 8733495; PMCID: PMC1090678.
Hanania NA, Belfort MA. Acute asthma in pregnancy. Crit Care Med 2005 Oct;33(10 Suppl):S319-324. doi: 10.1097/01.ccm.0000182789.14710.a1. PMID: 16215354.
Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 2005 Apr;25(4):731-750. doi: 10.1183/09031936.05.00085704. PMID: 15802351.
Lim A, Stewart K, König K, George J. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother 2011 Jul;45(7-8):931-945. doi: 10.1345/aph.1P764. Epub 2011 Jun 28. PMID: 21712513.
Bjørn AM, Ehrenstein V, Nohr EA, Nørgaard M. Use of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriage. Basic Clin Pharmacol Toxicol 2015 Apr;116(4):308-314. doi: 10.1111/bcpt.12367. Epub 2015 Jan 22. PMID: 25515299.
Kelly W, Massoumi A, Lazarus A. Asthma in pregnancy: Physiology, diagnosis, and management. Postgrad Med 2015 May;127(4):349-358. doi: 10.1080/00325481.2015.1016386. Epub 2015 Feb 23. PMID: 25702799.
Zanforlin A, Corsico AG, DI Marco F, Patella V, Scichilone N. Asthma in pregnancy: one more piece of the puzzle. Minerva Med 2016 Feb;107(1 Suppl 1):1-4. PMID: 27427392.
Gonzalez-Estrada A, Geraci SA. Allergy Medications During Pregnancy. Am J Med Sci 2016 Sep;352(3):326-331. doi: 10.1016/j.amjms.2016.05.030. Epub 2016 Jun 3. PMID: 27650241.
Bonham CA, Patterson KC, Strek ME. Asthma outcomes and management during pregnancy. Chest 2018 Feb;153(2):515-527. doi: 10.1016/j.chest.2017.08.029. Epub 2017 Sep 1. PMID: 28867295; PMCID: PMC5815874.
Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo CA Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999 Sep;160(3):887-892. doi: 10.1164/ajrccm.160.3.9812138. PMID: 10471614.
McCallister JW, Benninger CG, Frey HA, Phillips GS, Mastronarde JG. Pregnancy related treatment disparities of acute asthma exacerbations in the emergency department. Respir Med 2011 Oct;105(10):1434-1440. doi: 10.1016/j.rmed.2011.05.015. Epub 2011 Jun 22. PMID: 21700439.
Pfaller B, José Yepes-Nuñez J, Agache I, Akdis CA, Alsalamah M, Bavbek S, Bossios A, Boyman O, Chaker A, Chan S, Chatzipetrou A, du Toit G, Jutel M, Kauppi P, Kolios A, Li C, Matucci A, Marson A, Bendien S, Palomares O, Rogala B, Szepfalusi Z, Untersmayr E, Vultaggio A, Eiwegger T. Biologicals in atopic disease in pregnancy: An EAACI position paper. Allergy 2021 Jan;76(1):71-89. doi: 10.1111/all.14282. PMID: 32189356.
Namazy J, Cabana MD, Scheuerle AE, Thorp JM Jr, Chen H, Carrigan G, Wang Y, Veith J, Andrews EB. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015 Feb;135(2):407-12. doi: 10.1016/j.jaci.2014.08.025. Epub 2014 Oct 19. PMID: 25441639.
Türk Toraks Derneği Astım Tanı ve Tedavi Rehberi, Astımın Kronik Tedavisi, Basamak Tedavisi, 2022 Güncellemesi, Ankara; 2022. ISBN: 978-605-74980-9-0.
Grosso A, Locatelli F, Gini E, Albicini F, Tirelli C, Cerveri I, Corsico AG. The course of asthma during pregnancy in a recent, multicase-control study on respiratory health. Allergy Asthma Clin Immunol 2018 Apr 17;14:16. doi: 10.1186/s13223-018-0242-0. PMID: 29692816; PMCID: PMC5902995.
George J, Abramson MJ, Walker SP. Asthma in pregnancy: are inhaled corticosteroids safe? Am J Respir Crit Care Med 2012 Mar 1;185(5):476-478. doi: 10.1164/rccm.201112-2249ED. PMID: 22383568.
